Yüklüyor......
Phase II Trials for Heterogeneous Patient Populations with a Time-to-Event Endpoint
In this paper, we consider a single-arm phase II trial with a time-to-event end-point. We assume that the study population has multiple subpopulations with different prognosis, but the study treatment is expected to be similarly efficacious across the subpopulations. We review a stratified one-sampl...
Kaydedildi:
| Yayımlandı: | Med Res Arch |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5749428/ https://ncbi.nlm.nih.gov/pubmed/29302620 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|